ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
= 6 7 6 7 O
1,000 8 13 8 13 B-lower_bound
/ 13 14 13 14 I-lower_bound
uL 14 16 14 16 I-lower_bound

AST(SGOT)/ALT(SGPT 0 18 17 35 B-clinical_variable
) 18 19 35 36 I-clinical_variable
< 20 21 37 38 O
= 22 23 39 40 O
2.5 24 27 41 44 B-upper_bound
X 28 29 45 46 I-upper_bound
upper 30 35 47 52 I-upper_bound
limit 36 41 53 58 I-upper_bound
of 42 44 59 61 I-upper_bound
normal 45 51 62 68 I-upper_bound

Age 0 3 69 72 B-age
> 4 5 73 74 O
= 6 7 75 76 O
18 8 10 77 79 B-lower_bound
years 11 16 80 85 I-lower_bound

All 0 3 86 89 O
patients 4 12 90 98 O
who 13 16 99 102 O
participate 17 28 103 114 O
in 29 31 115 117 O
this 32 36 118 122 O
study 37 42 123 128 O
must 43 47 129 133 O
be 48 50 134 136 O
willing 51 58 137 144 O
and 59 62 145 148 O
able 63 67 149 153 O
to 68 70 154 156 O
tolerate 71 79 157 165 O
prophylactic 80 92 166 178 B-treatment
anticoagulation 93 108 179 194 I-treatment
with 109 113 195 199 I-treatment
low 114 117 200 203 I-treatment
- 117 118 203 204 I-treatment
molecular 118 127 204 213 I-treatment
weight 128 134 214 220 I-treatment
heparin 135 142 221 228 I-treatment
( 143 144 229 230 I-treatment
LMWH 144 148 230 234 I-treatment
) 148 149 234 235 I-treatment
for 150 153 236 239 O
the 154 157 240 243 O
required 158 166 244 252 O
dates 167 172 253 258 O
in 173 175 259 261 O
treatment 176 185 262 271 B-treatment
protocol 186 194 272 280 I-treatment

Cardiac 0 7 281 288 B-clinical_variable
Ejection 8 16 289 297 I-clinical_variable
Fraction 17 25 298 306 I-clinical_variable
> 26 27 307 308 O
= 28 29 309 310 O
45 30 32 311 313 B-lower_bound
% 33 34 314 315 I-lower_bound

Creatinine 0 10 316 326 B-clinical_variable
clearance 11 20 327 336 I-clinical_variable
> 21 22 337 338 O
60 23 25 339 341 B-lower_bound
cc 26 28 342 344 I-lower_bound
/ 28 29 344 345 I-lower_bound
min 29 32 345 348 I-lower_bound

ECOG 0 4 349 353 B-clinical_variable
performance 5 16 354 365 I-clinical_variable
status 17 23 366 372 I-clinical_variable
> 24 25 373 374 O
= 26 27 375 376 O
2 28 29 377 378 B-lower_bound

FCBP 0 4 379 383 O
must 5 9 384 388 O
also 10 14 389 393 O
agree 15 20 394 399 O
to 21 23 400 402 O
ongoing 24 31 403 410 O
pregnancy 32 41 411 420 B-pregnancy
testing 42 49 421 428 O

Females 0 7 429 436 B-gender
of 8 10 437 439 O
childbearing 11 23 440 452 O
potential 24 33 453 462 O
( 34 35 463 464 O
FCBP 35 39 464 468 O
) 39 40 468 469 O
must 41 45 470 474 O
have 46 50 475 479 O
a 51 52 480 481 O
negative 53 61 482 490 B-pregnancy
serum 62 67 491 496 I-pregnancy
or 68 70 497 499 I-pregnancy
urine 71 76 500 505 I-pregnancy
pregnancy 77 86 506 515 I-pregnancy
test 87 91 516 520 O
with 92 96 521 525 O
a 97 98 526 527 O
sensitivity 99 110 528 539 O
of 111 113 540 542 O
at 114 116 543 545 O
least 117 122 546 551 O
50 123 125 552 554 B-lower_bound
mIU 126 129 555 558 I-lower_bound
/ 129 130 558 559 I-lower_bound
mL 130 132 559 561 I-lower_bound
within 133 139 562 568 O
10 140 142 569 571 B-lower_bound
- 143 144 572 573 O
14 145 147 574 576 B-upper_bound
days 148 152 577 581 I-upper_bound
and 153 156 582 585 O
again 157 162 586 591 O
within 163 169 592 598 O
24 170 172 599 601 B-upper_bound
hours 173 178 602 607 I-upper_bound
prior 179 184 608 613 I-upper_bound
to 185 187 614 616 O
prescribing 188 199 617 628 O
lenalidomide 200 212 629 641 B-treatment
( 213 214 642 643 O
prescriptions 214 227 643 656 O
must 228 232 657 661 O
be 233 235 662 664 O
filled 236 242 665 671 O
within 243 249 672 678 O
7 250 251 679 680 B-upper_bound
days 252 256 681 685 I-upper_bound
) 256 257 685 686 O

History 0 7 687 694 O
of 8 10 695 697 O
allergic 11 19 698 706 O
reactions 20 29 707 716 O
attributed 30 40 717 727 O
to 41 43 728 730 O
compounds 44 53 731 740 O
of 54 56 741 743 O
similar 57 64 744 751 O
chemical 65 73 752 760 O
or 74 76 761 763 O
biologic 77 85 764 772 O
composition 86 97 773 784 O
to 98 100 785 787 O
lenalidomide 101 113 788 800 B-allergy_name
( 114 115 801 802 O
including 115 124 802 811 O
thalidomide 125 136 812 823 B-allergy_name
) 136 137 823 824 O
or 138 140 825 827 O
melphalan 141 150 828 837 B-allergy_name

History 0 7 838 845 O
of 8 10 846 848 O
thrombosis 11 21 849 859 B-chronic_disease
or 22 24 860 862 O
thromboembolic 25 39 863 877 B-chronic_disease
event 40 45 878 883 I-chronic_disease
within 46 52 884 890 O
last 53 57 891 895 B-upper_bound
60 58 60 896 898 I-upper_bound
days 61 65 899 903 I-upper_bound
prior 66 71 904 909 I-upper_bound
to 72 74 910 912 O
study 75 80 913 918 O
entry 81 86 919 924 O

Known 0 5 925 930 O
positive 6 14 931 939 O
for 15 18 940 943 O
HIV 19 22 944 947 B-chronic_disease
or 23 25 948 950 O
infectious 26 36 951 961 O
hepatitis 37 46 962 971 B-chronic_disease
, 46 47 971 972 I-chronic_disease
type 48 52 973 977 I-chronic_disease
B 53 54 978 979 I-chronic_disease
or 55 57 980 982 I-chronic_disease
C 58 59 983 984 I-chronic_disease

Lenalidomide 0 12 985 997 B-treatment
has 13 16 998 1001 O
been 17 21 1002 1006 O
shown 22 27 1007 1012 O
to 28 30 1013 1015 O
carry 31 36 1016 1021 O
a 37 38 1022 1023 O
risk 39 43 1024 1028 O
of 44 46 1029 1031 O
thromboembolic 47 61 1032 1046 B-chronic_disease
events 62 68 1047 1053 I-chronic_disease
, 68 69 1053 1054 O
especially 70 80 1055 1065 O
when 81 85 1066 1070 O
used 86 90 1071 1075 O
in 91 93 1076 1078 O
combination 94 105 1079 1090 O
with 106 110 1091 1095 O
either 111 117 1096 1102 O
corticosteroids 118 133 1103 1118 B-treatment
or 134 136 1119 1121 O
alkylating 137 147 1122 1132 B-treatment
chemotherapeutic 148 164 1133 1149 I-treatment
agents 165 171 1150 1156 I-treatment

Life 0 4 1157 1161 B-clinical_variable
expectancy 5 15 1162 1172 I-clinical_variable
of 16 18 1173 1175 O
greater 19 26 1176 1183 O
than 27 31 1184 1188 O
12 32 34 1189 1191 B-lower_bound
weeks 35 40 1192 1197 I-lower_bound

Men 0 3 1198 1201 B-gender
must 4 8 1202 1206 O
agree 9 14 1207 1212 B-contraception_consent
to 15 17 1213 1215 I-contraception_consent
use 18 21 1216 1219 I-contraception_consent
a 22 23 1220 1221 I-contraception_consent
latex 24 29 1222 1227 I-contraception_consent
condom 30 36 1228 1234 I-contraception_consent
during 37 43 1235 1241 O
sexual 44 50 1242 1248 O
contact 51 58 1249 1256 O
with 59 63 1257 1261 O
a 64 65 1262 1263 O
FCBP 66 70 1264 1268 B-clinical_variable
even 71 75 1269 1273 O
if 76 78 1274 1276 O
they 79 83 1277 1281 O
have 84 88 1282 1286 O
had 89 92 1287 1290 O
a 93 94 1291 1292 O
successful 95 105 1293 1303 O
vasectomy 106 115 1304 1313 B-treatment

Patients 0 8 1314 1322 O
also 9 13 1323 1327 O
must 14 18 1328 1332 O
be 19 21 1333 1335 O
able 22 26 1336 1340 O
to 27 29 1341 1343 O
tolerate 30 38 1344 1352 O
low 39 42 1353 1356 O
- 42 43 1356 1357 O
dose 43 47 1357 1361 O
aspirin 48 55 1362 1369 B-treatment
, 55 56 1369 1370 O
81 57 59 1371 1373 O
mg 60 62 1374 1376 O
daily 63 68 1377 1382 O
, 68 69 1382 1383 O
during 70 76 1384 1390 O
the 77 80 1391 1394 O
maintenance 81 92 1395 1406 O
phase 93 98 1407 1412 O
of 99 101 1413 1415 O
the 102 105 1416 1419 O
treatment 106 115 1420 1429 B-treatment
protocol 116 124 1430 1438 O

Patients 0 8 1439 1447 O
may 9 12 1448 1451 O
have 13 17 1452 1456 O
received 18 26 1457 1465 O
bisphosphonate 27 41 1466 1480 B-treatment
therapy 42 49 1481 1488 I-treatment
as 50 52 1489 1491 O
part 53 57 1492 1496 O
of 58 60 1497 1499 O
routine 61 68 1500 1507 O
myeloma 69 76 1508 1515 B-cancer
care 77 81 1516 1520 O
at 82 84 1521 1523 O
any 85 88 1524 1527 O
time 89 93 1528 1532 O
prior 94 99 1533 1538 O
to 100 102 1539 1541 O
study 103 108 1542 1547 O
entry 109 114 1548 1553 O

Patients 0 8 1554 1562 O
may 9 12 1563 1566 O
not 13 16 1567 1570 O
be 17 19 1571 1573 O
receiving 20 29 1574 1583 O
any 30 33 1584 1587 O
other 34 39 1588 1593 O
investigational 40 55 1594 1609 B-treatment
agents 56 62 1610 1616 I-treatment

Patients 0 8 1617 1625 O
must 9 13 1626 1630 O
have 14 18 1631 1635 O
an 19 21 1636 1638 O
adequate 22 30 1639 1647 O
number 31 37 1648 1654 O
of 38 40 1655 1657 O
CD34 41 45 1658 1662 O
+ 45 46 1662 1663 O
stem 47 51 1664 1668 O
cells 52 57 1669 1674 O
collected 58 67 1675 1684 O
to 68 70 1685 1687 O
allow 71 76 1688 1693 O
for 77 80 1694 1697 O
transplantation 81 96 1698 1713 B-treatment

Patients 0 8 1714 1722 O
must 9 13 1723 1727 O
have 14 18 1728 1732 O
histologically 19 33 1733 1747 O
or 34 36 1748 1750 O
cytologically 37 50 1751 1764 O
confirmed 51 60 1765 1774 O
relapsed 61 69 1775 1783 B-cancer
, 69 70 1783 1784 O
primary 71 78 1785 1792 B-cancer
refractory 79 89 1793 1803 I-cancer
, 89 90 1803 1804 O
or 91 93 1805 1807 O
relapsed 94 102 1808 1816 B-cancer
and 103 106 1817 1820 I-cancer
refractory 107 117 1821 1831 I-cancer
multiple 118 126 1832 1840 I-cancer
myeloma 127 134 1841 1848 I-cancer

Patients 0 8 1849 1857 O
who 9 12 1858 1861 O
have 13 17 1862 1866 O
had 18 21 1867 1870 O
myeloma 22 29 1871 1878 B-treatment
therapy 30 37 1879 1886 I-treatment
within 38 44 1887 1893 O
14 45 47 1894 1896 B-upper_bound
days 48 52 1897 1901 I-upper_bound
prior 53 58 1902 1907 I-upper_bound
to 59 61 1908 1910 O
entering 62 70 1911 1919 O
the 71 74 1920 1923 O
study 75 80 1924 1929 O
or 81 83 1930 1932 O
those 84 89 1933 1938 O
who 90 93 1939 1942 O
have 94 98 1943 1947 O
not 99 102 1948 1951 O
recovered 103 112 1952 1961 O
from 113 117 1962 1966 O
adverse 118 125 1967 1974 O
events 126 132 1975 1981 O
due 133 136 1982 1985 O
to 137 139 1986 1988 O
agents 140 146 1989 1995 O
administered 147 159 1996 2008 O
more 160 164 2009 2013 O
than 165 169 2014 2018 O
2 170 171 2019 2020 B-lower_bound
weeks 172 177 2021 2026 I-lower_bound
earlier 178 185 2027 2034 O

Pregnant 0 8 2035 2043 B-pregnancy
and 9 12 2044 2047 O
lactating 13 22 2048 2057 O
women 23 28 2058 2063 B-gender
are 29 32 2064 2067 O
excluded 33 41 2068 2076 O
from 42 46 2077 2081 O
the 47 50 2082 2085 O
study 51 56 2086 2091 O
because 57 64 2092 2099 O
the 65 68 2100 2103 O
risks 69 74 2104 2109 O
to 75 77 2110 2112 O
an 78 80 2113 2115 O
unborn 81 87 2116 2122 O
fetus 88 93 2123 2128 O
or 94 96 2129 2131 O
potential 97 106 2132 2141 O
risks 107 112 2142 2147 O
in 113 115 2148 2150 O
nursing 116 123 2151 2158 O
infants 124 131 2159 2166 O
are 132 135 2167 2170 O
unknown 136 143 2171 2178 O

Should 0 6 2179 2185 O
a 7 8 2186 2187 O
woman 9 14 2188 2193 B-gender
become 15 21 2194 2200 B-pregnancy
pregnant 22 30 2201 2209 I-pregnancy
or 31 33 2210 2212 O
suspect 34 41 2213 2220 O
she 42 45 2221 2224 O
is 46 48 2225 2227 O
pregnant 49 57 2228 2236 O
while 58 63 2237 2242 O
participating 64 77 2243 2256 O
in 78 80 2257 2259 O
this 81 85 2260 2264 O
study 86 91 2265 2270 O
, 91 92 2270 2271 O
she 93 96 2272 2275 O
should 97 103 2276 2282 O
inform 104 110 2283 2289 O
her 111 114 2290 2293 O
treating 115 123 2294 2302 O
physician 124 133 2303 2312 O
immediately 134 145 2313 2324 O

The 0 3 2325 2328 O
effects 4 11 2329 2336 O
of 12 14 2337 2339 O
lenalidomide 15 27 2340 2352 B-treatment
on 28 30 2353 2355 O
the 31 34 2356 2359 O
developing 35 45 2360 2370 O
human 46 51 2371 2376 O
fetus 52 57 2377 2382 O
at 58 60 2383 2385 O
the 61 64 2386 2389 O
recommended 65 76 2390 2401 O
therapeutic 77 88 2402 2413 O
dose 89 93 2414 2418 O
are 94 97 2419 2422 O
unknown 98 105 2423 2430 O
; 105 106 2430 2431 O
however 107 114 2432 2439 O
, 114 115 2439 2440 O
it 116 118 2441 2443 O
has 119 122 2444 2447 O
been 123 127 2448 2452 O
shown 128 133 2453 2458 O
to 134 136 2459 2461 O
be 137 139 2462 2464 O
teratogenic 140 151 2465 2476 B-treatment
other 152 157 2477 2482 O
primates 158 166 2483 2491 O

The 0 3 2492 2495 O
treating 4 12 2496 2504 O
physician 13 22 2505 2514 O
will 23 27 2515 2519 O
follow 28 34 2520 2526 O
the 35 38 2527 2530 O
adverse 39 46 2531 2538 O
reporting 47 56 2539 2548 O
guidelines 57 67 2549 2559 O
as 68 70 2560 2562 O
outlined 71 79 2563 2571 O
in 80 82 2572 2574 O
further 83 90 2575 2582 O
detail 91 97 2583 2589 O
below 98 103 2590 2595 O
for 104 107 2596 2599 O
pregnancies 108 119 2600 2611 B-pregnancy

This 0 4 2612 2616 O
number 5 11 2617 2623 O
is 12 14 2624 2626 O
defined 15 22 2627 2634 O
as 23 25 2635 2637 O
≥ 26 27 2638 2639 O
2 28 29 2640 2641 B-lower_bound
x 30 31 2642 2643 I-lower_bound
106 32 35 2644 2647 I-lower_bound
CD34 36 40 2648 2652 I-lower_bound
+ 40 41 2652 2653 I-lower_bound
cells 42 47 2654 2659 I-lower_bound
/ 48 49 2660 2661 I-lower_bound
kg 50 52 2662 2664 I-lower_bound
body 53 57 2665 2669 B-clinical_variable
weight 58 64 2670 2676 I-clinical_variable

Uncontrolled 0 12 2677 2689 B-chronic_disease
illness 13 20 2690 2697 I-chronic_disease
including 21 30 2698 2707 O
, 30 31 2707 2708 O
but 32 35 2709 2712 O
not 36 39 2713 2716 O
limited 40 47 2717 2724 O
to 48 50 2725 2727 O
, 50 51 2727 2728 O
ongoing 52 59 2729 2736 O
or 60 62 2737 2739 O
active 63 69 2740 2746 B-chronic_disease
infection 70 79 2747 2756 I-chronic_disease
, 79 80 2756 2757 O
symptomatic 81 92 2758 2769 O
congestive 93 103 2770 2780 B-chronic_disease
heart 104 109 2781 2786 I-chronic_disease
failure 110 117 2787 2794 I-chronic_disease
, 117 118 2794 2795 O
unstable 119 127 2796 2804 B-chronic_disease
angina 128 134 2805 2811 I-chronic_disease
pectoris 135 143 2812 2820 I-chronic_disease
, 143 144 2820 2821 O
cardiac 145 152 2822 2829 B-chronic_disease
arrhythmia 153 163 2830 2840 I-chronic_disease
, 163 164 2840 2841 O
or 165 167 2842 2844 O
psychiatric 168 179 2845 2856 B-chronic_disease
illness 180 187 2857 2864 I-chronic_disease
/ 187 188 2864 2865 I-chronic_disease
social 188 194 2865 2871 I-chronic_disease
situations 195 205 2872 2882 I-chronic_disease
that 206 210 2883 2887 O
would 211 216 2888 2893 O
limit 217 222 2894 2899 O
compliance 223 233 2900 2910 O
with 234 238 2911 2915 O
study 239 244 2916 2921 O
requirements 245 257 2922 2934 O

at 0 2 2935 2937 O
least 3 8 2938 2943 O
28 9 11 2944 2946 B-lower_bound
days 12 16 2947 2951 I-lower_bound
before 17 23 2952 2958 O
she 24 27 2959 2962 O
starts 28 34 2963 2969 O
taking 35 41 2970 2976 O
lenalidomide 42 54 2977 2989 B-treatment

involved 0 8 2990 2998 O
free 9 13 2999 3003 B-clinical_variable
light 14 19 3004 3009 I-clinical_variable
chain 20 25 3010 3015 I-clinical_variable
> 26 27 3016 3017 O
= 28 29 3018 3019 O
10mg 30 34 3020 3024 B-lower_bound
/ 34 35 3024 3025 I-lower_bound
dL 35 37 3025 3027 I-lower_bound
provided 38 46 3028 3036 O
serum 47 52 3037 3042 B-clinical_variable
free 53 57 3043 3047 I-clinical_variable
light 58 63 3048 3053 I-clinical_variable
chain 64 69 3054 3059 I-clinical_variable
ratio 70 75 3060 3065 O
is 76 78 3066 3068 O
abnormal 79 87 3069 3077 O

must 0 4 3078 3082 O
either 5 11 3083 3089 O
commit 12 18 3090 3096 B-contraception_consent
to 19 21 3097 3099 I-contraception_consent
continued 22 31 3100 3109 I-contraception_consent
abstinence 32 42 3110 3120 I-contraception_consent
from 43 47 3121 3125 I-contraception_consent
heterosexual 48 60 3126 3138 I-contraception_consent
intercourse 61 72 3139 3150 I-contraception_consent
or 73 75 3151 3153 O
begin 76 81 3154 3159 B-contraception_consent
TWO 82 85 3160 3163 I-contraception_consent
acceptable 86 96 3164 3174 I-contraception_consent
methods 97 104 3175 3182 I-contraception_consent
of 105 107 3183 3185 I-contraception_consent
birth 108 113 3186 3191 I-contraception_consent
control 114 121 3192 3199 I-contraception_consent
, 121 122 3199 3200 O
one 123 126 3201 3204 O
highly 127 133 3205 3211 O
effective 134 143 3212 3221 O
method 144 150 3222 3228 O
and 151 154 3229 3232 O
one 155 158 3233 3236 O
additional 159 169 3237 3247 O
effective 170 179 3248 3257 O
method 180 186 3258 3264 O
AT 187 189 3265 3267 O
THE 190 193 3268 3271 O
SAME 194 198 3272 3276 O
TIME 199 203 3277 3281 O

platelets 0 9 3282 3291 B-clinical_variable
> 10 11 3292 3293 O
= 12 13 3294 3295 O
50,000 14 20 3296 3302 B-lower_bound
/ 20 21 3302 3303 I-lower_bound
uL 21 23 3303 3305 I-lower_bound

serum 0 5 3306 3311 B-clinical_variable
M 6 7 3312 3313 I-clinical_variable
- 7 8 3313 3314 I-clinical_variable
protein 8 15 3314 3321 I-clinical_variable
of 16 18 3322 3324 O
> 19 20 3325 3326 O
= 21 22 3327 3328 O
500mg 23 28 3329 3334 B-lower_bound
/ 28 29 3334 3335 I-lower_bound
dL 29 31 3335 3337 I-lower_bound

total 0 5 3338 3343 B-clinical_variable
bilirubin 6 15 3344 3353 I-clinical_variable
< 16 17 3354 3355 O
= 18 19 3356 3357 O
1.5 20 23 3358 3361 B-upper_bound
X 24 25 3362 3363 I-upper_bound
upper 26 31 3364 3369 I-upper_bound
limit 32 37 3370 3375 I-upper_bound
of 38 40 3376 3378 I-upper_bound
normal 41 47 3379 3385 I-upper_bound

urine 0 5 3386 3391 B-clinical_variable
M 6 7 3392 3393 I-clinical_variable
- 7 8 3393 3394 I-clinical_variable
protein 8 15 3394 3401 I-clinical_variable
of 16 18 3402 3404 O
> 19 20 3405 3406 O
= 21 22 3407 3408 O
200mg/ 23 29 3409 3415 B-lower_bound
24 30 32 3416 3418 I-lower_bound
hours 33 38 3419 3424 I-lower_bound

